3-Hydroxyoctanoic Acid

CAS No. 14292-27-4

3-Hydroxyoctanoic Acid( —— )

Catalog No. M28858 CAS No. 14292-27-4

3-Hydroxyoctanoic Acid is one of the hydroxy-carboxylic acids (HCAs) that serve as intermediates of energy metabolism. It is an agonist of the orphan receptor GPR109B.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 In Stock
10MG 49 In Stock
25MG 85 In Stock
50MG 129 In Stock
100MG 184 In Stock
200MG Get Quote In Stock
500MG 479 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Hydroxyoctanoic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Hydroxyoctanoic Acid is one of the hydroxy-carboxylic acids (HCAs) that serve as intermediates of energy metabolism. It is an agonist of the orphan receptor GPR109B.
  • Description
    3-Hydroxyoctanoic Acid is one of the hydroxy-carboxylic acids (HCAs) that serve as intermediates of energy metabolism. It is an agonist of the orphan receptor GPR109B.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    D3 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14292-27-4
  • Formula Weight
    160.21
  • Molecular Formula
    C8H16O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 42.5 mg/mL (265.28 mM)
  • SMILES
    CCCCCC(CC(O)=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rudmann DG, et al. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864. Toxicol Pathol. 2004 May-Jun;32(3):326-32.
molnova catalog
related products
  • WAY-622024

    WAY-622024 is an agonist of the orphan human GPCR GPR109B.

  • ML 145

    ML 145 is a selective and potent antagonist of human GPR35, with no significant activity against GPR35 in any of its immediate rodent homologs.

  • Myristyl nicotinate

    Myristyl nicotinate is an ester prodrug being developed for delivery of nicotinic acid (NIC) into the skin for prevention of actinic keratosis and its progression to skin cancer.